Why this Newsletter
To let you know of an upcoming national meeting focused on how wireless medical devices are changing the innovation process, the delivery of clinical care and healthcare provider reimbursement models.
****
For those innovators not developing medical apps and telemedicine, it is these technologies (apps and telemedicine) which are changing the delivery of healthcare and in doing so could present unforeseen opportunities for medical devices and molecular IVD diagnostic tests.
The 4th Annual Medical Devices Summit West to be held on July 10-11, 2014, and sponsored by Opal Events, will focus on how wireless medical devices can and are becoming an integral part of the overall healthcare delivery system. Sophisticated information platforms are built into medical devices, wireless devices are rapidly evolving, and connectivity and interoperability all make this possible.
Join Susan Rowinski , President & CEO of Rowinski Group, and other presenters will lead discussions on how the next generation medical devices are transforming the way healthcare is delivered and reimbursed; learn how they got there and what they are doing to stay ahead. Susan will be speaking about ‘How Smart Phone Telemedicine is Reinventing Healthcare Delivery and Reimbursement Approvals’ starting at 10 am on July 11.
The Medical Devices Summit West will be held in the San Francisco Bay Area For more information and to register go to http://www.opalevents.org/trk/mdswc1415.html or contact Jennifer Osorio, Business Development, at josorio@opalevents.org or 212.532.9898 ext. 285.
****
About Rowinski Group
Founded in 2004, Rowinski Group LLC is a reimbursement and healthcare payer data analytics consulting firm for medical device, digital health, diagnostics, and imaging companies. Rowinski Group is based in Silicon Valley – San Francisco bay area with offices at selected client locations.
Rowinski Group has two core service offerings; securing codes and reimbursement on behalf of companies and applying healthcare payer data analytics to help solve companies’ complex business issues such as responding to questions from the FDA and U.S. Payers.
Through these service offerings Rowinski Group helps U.S. and international companies build their U.S. market share for the medical technology they are developing and selling. For more information visit www.rowinskigroup.com
